Skip to main content
    A

    Actinium Pharmaceuticals Inc (ATNM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $1.33
    -0.16 (-10.74%)

    Market Cap: $46.85M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Actinium Pharmaceuticals Inc (ATNM) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Actinium Pharmaceuticals (ATNM) has a latest price of $1.33 on Nov 17, 2026, 22.7% below its 52-week high of $1.72. Its price rose 4.7% over the past 12 months. The month-end price fell 94.8% over the 10 years through Oct 2026, a compound annual decline of 25.6%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $45.35 in Mar 2017 and its lowest $0.84 in Jul 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart ATNM with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ATNM.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 17.7%, and over 6 months it rose 15.7%. The month-end price fell 73.5% over the 3 years through Oct 2026, a compound annual decline of 35.7%.

    PeriodChange
    1 month+0.8%
    3 months+17.7%
    6 months+15.7%
    12 months+4.7%
    12 months, with dividends+4.7%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-73.5%-35.7%
    5 years-81.1%-28.4%
    10 years-94.8%-25.6%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2022, when the price rose 77.2%, and its weakest was 2024, when it fell 75.2%.

    YearCloseChange
    2026 through Oct 2026$1.48+8.8%
    2025$1.36+7.9%
    2024$1.26-75.2%
    2023$5.08-52.3%
    2022$10.65+77.2%
    2021$6.01-22.9%
    2020$7.80+19.1%
    2019$6.55-43.7%
    2018$11.62-41.7%
    2017$19.94-24.1%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 2.7% above its 50-day average of $1.30 and 17.4% above its 200-day average of $1.13.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.33
    52-week high$1.72-22.7%
    52-week low$0.73+81.0%
    50-day average$1.30+2.7%
    200-day average$1.13+17.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 92.4%.

    MeasureValue
    1-year beta0.83
    Largest fall, 1 year-55.7%
    Largest fall, 3 years-92.4%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About ATNM

    What is ATNM's 1-year price change?

    Actinium Pharmaceuticals's price rose 4.7% over the past 12 months. With dividends included, the 12-month total return was 4.7%.

    What is ATNM's 5-year price change?

    Actinium Pharmaceuticals's month-end price fell 81.1% over the 5 years through Oct 2026, a compound annual decline of 28.4%. These figures leave out dividends.

    What is ATNM's 52-week high and low?

    Actinium Pharmaceuticals's 52-week high is $1.72 and its 52-week low is $0.73. Its latest price of $1.33 on Nov 17, 2026 is 22.7% below the high.

    What is ATNM's beta?

    Actinium Pharmaceuticals's 1-year beta against the S&P 500 is 0.83, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 55.7%.

    Is the ATNM chart free?

    Yes. Advanced Charting for ATNM is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.